Combined severe factor XII deficiency and homozygous factor V Leiden mutation in a patient with venous thrombosis [2]

Thrombosis Research

Volumn 106, Issue 4-5, 2002, Pages 265-267

  Miljic, P ^a   Colovic, M ^a   Rakicevic, Lj ^b   Djordjevic, V ^b   Boskovic, D ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b Institute of Molecular Genetics and Genetic Engineering   (Serbia)

Author keywords

Factor V Leiden mutation; Factor XII deficiency; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 5;

ADULT; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DOPPLER ECHOGRAPHY; FEMALE; GENE MUTATION; HEMOSTASIS; HETEROZYGOSITY; HUMAN; LETTER; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VEIN THROMBOSIS; BLOOD; BLOOD CLOTTING FACTOR 12 DEFICIENCY; FAMILY HEALTH; GENETICS; HOMOZYGOTE; PREGNANCY; PUERPERAL DISORDER;

ADULT; FACTOR V; FACTOR XII DEFICIENCY; FAMILY HEALTH; FEMALE; HOMOZYGOTE; HUMANS; PREGNANCY; PUERPERAL DISORDERS; VENOUS THROMBOSIS;

EID: 0037092633     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00129-9     Document Type: Letter

References (10)

1. Colman W.R. Biologic activities of the contact factors in vivo. Potentiation of hypotension, inflammation, and fibrinolysis, and inhibition of cell adhesion, angiogenesis and thrombosis. Thromb. Haemost. 82:1999;1568-1577.
2. Zeerleder S., Schloesser M., Redondo M.et al. Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency. A study on 73 subjects from 14 Sviss families. Thromb. Haemost. 82:1999;1240-1246.
3. Colovic M.D., Miljic P., Colovic R.B., Jankovic G. Inherited combined deficiency of factors XI and XII with von Willebrand's disease. Haemophilia. 2:1996;250-252.
4. Castaman G., Ruggeri M., Tosetto A., Missiaglia E., Rodeghiero F. Thrombosis in patients with heterozygous and homozygous factor XII deficiency is not explained by the associated presence of factor V Leiden. Thromb. Haemost. 76:1996;275.
5. Lane A.D., Mannucci M.P., Bauer A.K.et al. Inherited thrombophilia: part 1. Thromb. Haemost. 76:1996;651-662.
6. Koeleman B.P.C., Reitsma P.H., Allaart C.F., Bertina R.M. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood. 84:1994;1031-1035.
7. Zöller B., Berntsdotter A., Garcia de Frutos P., Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood. 85:1995;3518-3523.
8. Van Boven H.H., Retsma P.H., Rosendaal F.R., Bayston T.A., Chowdhury V., Bauer K.A.et al. Factor Leiden (F V R506Q) in families with inherited antithrombin deficiency. Thromb. Haemost. 75:1996;417-421.
9. Girolami A., Simioni P., Scarano L., Girolami B., Zerbinati P. Symptomatic combined homozygous factor XII deficiency and heterozygous factor V Leiden. J. Thromb. Thrombolysis. 9:2000;271-275.
10. Stevensson J.P., Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. NEJM. 330:1994;517-522.